Table 4. Multivariate analysis of clinical characteristics, pathologic parameters, and genetic alterations with biochemical recurrence.

Characteristic	Multivariate analysis
	HR (95% CI)	p-value
Prostate volume (>50 mL)	0.12 (0.01–0.74)	0.02
Pathologic Gleason grade group		0.03
3	Reference
4–5	4.11 (1.14–14.88)
Pathologic T stage		0.09
T3a	Reference
T3b	2.81 (0.84–9.78)
Intraductal carcinoma		0.22
BRAF mutation	9.84 (2.27–149.18)	0.03

HR, hazard ratio; CI, confidence interval.